William-May Stubblefield

Assistant Professor

Vanderbilt University Medical Center

United States

Research Interests

Explore related searches

Professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

William-May Stubblefield is an Assistant Professor at Vanderbilt University Medical Center in the United States. His research focuses on pulmonary embolism, COVID-19 vaccination effectiveness, and cardiovascular health outcomes. Recent articles include investigations into the safety of ruling out pulmonary embolism and the impact of mRNA vaccines on hospitalization rates among various demographics.

Articles (14)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Collaborators (6)

Jonathan Casey

Assistant Professor

Vanderbilt University Medical Center

UNITED STATES

View details

Dandan Liu

UNITED STATES

View details

Phillip Levy

UNITED STATES

View details

Federico Germini

Assistant Professor

McMaster University

ITALY

View details

Candace D. McNaughton

UNITED STATES

View details

Dieuwke Luijten

Leiden University Medical Center

NETHERLANDS

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

William-May Stubblefield

Research Interests

Explore related searches

Contact this professor

About

Articles (14)

Ruling out pulmonary embolism safely: Standardized reporting of the failure rate

Effectiveness of the Original Monovalent Messenger RNA Coronavirus Disease 2019 (COVID-19) Vaccination Series Against Hospitalization for COVID-19–Associated Venous Thromboembolism

Preemptive anticoagulation during antenatal pulmonary embolism diagnostics in a community setting: retrospective cohort study

Platelet activation in patients with peripheral artery disease from 43 sites: Assessment of samples transported by overnight mail

Addressing the rising trend of high‐risk pulmonary embolism mortality: Clinical and research priorities

Delirium and its association with short-term outcomes in younger and older patients with acute heart failure

Association Between mRNA Vaccination and COVID-19 Hospitalization and Disease Severity.

Influenza Vaccine Effectiveness for Prevention of Severe Influenza-Associated Illness Among Adults in the United States, 2019-2020: A Test-Negative Study.

Improvement in Kansas City Cardiomyopathy Questionnaire Scores After a Self-Care Intervention in Patients With Acute Heart Failure Discharged From the Emergency Department

Effectiveness of mRNA vaccines in preventing COVID-19 hospitalization by age and burden of chronic medical conditions among immunocompetent US adults, March-August 2021.

Comparative Effectiveness of Moderna, Pfizer-BioNTech, and Janssen (Johnson & Johnson) Vaccines in Preventing COVID-19 Hospitalizations Among Adults Without Immunocompromising Conditions - United States, March-August 2021.

Sustained Effectiveness of Pfizer-BioNTech and Moderna Vaccines Against COVID-19 Associated Hospitalizations Among Adults - United States, March-July 2021.

Influenza vaccine acceptance and hesitancy among adults hospitalized with severe acute respiratory illnesses, United States 2019-2020.

Effectiveness of SARS-CoV-2 mRNA Vaccines for Preventing Covid-19 Hospitalizations in the United States.

Collaborators (6)

Jonathan Casey

Dandan Liu

Phillip Levy

Federico Germini

Candace D. McNaughton

Dieuwke Luijten

Make your next move.